STOCK TITAN

[Form 4] Neogen Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Neogen Corp (NEOG) insider transaction: John Patrick Moylan, Chief Accounting Officer and director, reported that on 08/18/2025 1,985 restricted stock units vested and were settled for 1,985 shares of common stock at a per-share value of $5.43. To cover obligations, 593 shares were disposed of at the same price, leaving Mr. Moylan with 14,347 shares beneficially owned after the transactions. The Form 4 was filed on 08/20/2025 and signed by an attorney-in-fact.

Operazione interna di Neogen Corp (NEOG): John Patrick Moylan, Chief Accounting Officer e membro del consiglio, ha dichiarato che il 08/18/2025 1.985 unità azionarie vincolate sono maturate e sono state convertite in 1.985 azioni ordinarie a un valore per azione di $5,43. Per coprire obblighi fiscali e contributivi, 593 azioni sono state vendute allo stesso prezzo, lasciando il Sig. Moylan con 14.347 azioni in proprietà effettiva dopo le operazioni. Il Modulo 4 è stato depositato il 08/20/2025 ed è stato firmato da un procuratore.

Operación interna de Neogen Corp (NEOG): John Patrick Moylan, Chief Accounting Officer y director, informó que el 08/18/2025 1.985 unidades de acciones restringidas vencieron y se liquidaron por 1.985 acciones ordinarias a un valor por acción de $5,43. Para cubrir obligaciones, 593 acciones fueron vendidas al mismo precio, dejando al Sr. Moylan con 14.347 acciones en propiedad efectiva tras las operaciones. El Formulario 4 se presentó el 08/20/2025 y fue firmado por un apoderado.

Neogen Corp (NEOG) 내부거래: 최고회계책임자(Chief Accounting Officer) 겸 이사인 John Patrick Moylan은 2025-08-18에 1,985개의 제한주식단위(RSU)가 성과·지급되어 1,985주의 보통주로 정산되었으며, 주당 가치는 $5.43였다고 보고했습니다. 세금·의무를 충당하기 위해 동일 가격으로 593주가 처분되어 거래 후 Moylan 씨는 총 14,347주의 실소유주로 남아 있습니다. Form 4는 2025-08-20에 제출되었고 대리인이 서명했습니다.

Transaction d'initié chez Neogen Corp (NEOG) : John Patrick Moylan, Chief Accounting Officer et administrateur, a déclaré que le 18/08/2025 1 985 unités d'actions restreintes ont acquis le droit et ont été réglées en 1 985 actions ordinaires à une valeur par action de 5,43 $. Pour couvrir des obligations, 593 actions ont été cédées au même prix, laissant M. Moylan avec 14 347 actions en propriété bénéficiaire après les opérations. Le formulaire 4 a été déposé le 20/08/2025 et signé par un mandataire.

Insider-Transaktion von Neogen Corp (NEOG): John Patrick Moylan, Chief Accounting Officer und Direktor, berichtete, dass am 18.08.2025 1.985 Restricted Stock Units fällig wurden und in 1.985 Stammaktien abgewickelt wurden zu einem Kurs von $5,43 pro Aktie. Zur Begleichung von Verpflichtungen wurden 593 Aktien zum gleichen Preis veräußert, wodurch Herr Moylan nach den Transaktionen 14.347 Aktien wirtschaftlich besitzt. Das Formular 4 wurde am 20.08.2025 eingereicht und von einem Bevollmächtigten unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting resulted in a modest net increase in insider holdings; no material market impact expected.

The reported activity shows 1,985 RSUs vesting and immediate settlement into common shares, with 593 shares sold concurrently, likely to satisfy tax withholding or related obligations. The per-share price reported ($5.43) is the accounting value used for the grant/settlement. Net change in beneficial ownership is small relative to typical public-company float and does not indicate a change in company control or an atypical liquidity event.

TL;DR: This is a standard executive compensation settlement and disclosure; governance procedures appear followed.

The Form 4 discloses RSU vesting and settlement consistent with equity compensation practices. The filing indicates the transaction was reported promptly and signed by an authorized attorney-in-fact. There is no disclosure of a Rule 10b5-1 plan or amendment, and no unusual timing or derivative activity beyond RSU settlement.

Operazione interna di Neogen Corp (NEOG): John Patrick Moylan, Chief Accounting Officer e membro del consiglio, ha dichiarato che il 08/18/2025 1.985 unità azionarie vincolate sono maturate e sono state convertite in 1.985 azioni ordinarie a un valore per azione di $5,43. Per coprire obblighi fiscali e contributivi, 593 azioni sono state vendute allo stesso prezzo, lasciando il Sig. Moylan con 14.347 azioni in proprietà effettiva dopo le operazioni. Il Modulo 4 è stato depositato il 08/20/2025 ed è stato firmato da un procuratore.

Operación interna de Neogen Corp (NEOG): John Patrick Moylan, Chief Accounting Officer y director, informó que el 08/18/2025 1.985 unidades de acciones restringidas vencieron y se liquidaron por 1.985 acciones ordinarias a un valor por acción de $5,43. Para cubrir obligaciones, 593 acciones fueron vendidas al mismo precio, dejando al Sr. Moylan con 14.347 acciones en propiedad efectiva tras las operaciones. El Formulario 4 se presentó el 08/20/2025 y fue firmado por un apoderado.

Neogen Corp (NEOG) 내부거래: 최고회계책임자(Chief Accounting Officer) 겸 이사인 John Patrick Moylan은 2025-08-18에 1,985개의 제한주식단위(RSU)가 성과·지급되어 1,985주의 보통주로 정산되었으며, 주당 가치는 $5.43였다고 보고했습니다. 세금·의무를 충당하기 위해 동일 가격으로 593주가 처분되어 거래 후 Moylan 씨는 총 14,347주의 실소유주로 남아 있습니다. Form 4는 2025-08-20에 제출되었고 대리인이 서명했습니다.

Transaction d'initié chez Neogen Corp (NEOG) : John Patrick Moylan, Chief Accounting Officer et administrateur, a déclaré que le 18/08/2025 1 985 unités d'actions restreintes ont acquis le droit et ont été réglées en 1 985 actions ordinaires à une valeur par action de 5,43 $. Pour couvrir des obligations, 593 actions ont été cédées au même prix, laissant M. Moylan avec 14 347 actions en propriété bénéficiaire après les opérations. Le formulaire 4 a été déposé le 20/08/2025 et signé par un mandataire.

Insider-Transaktion von Neogen Corp (NEOG): John Patrick Moylan, Chief Accounting Officer und Direktor, berichtete, dass am 18.08.2025 1.985 Restricted Stock Units fällig wurden und in 1.985 Stammaktien abgewickelt wurden zu einem Kurs von $5,43 pro Aktie. Zur Begleichung von Verpflichtungen wurden 593 Aktien zum gleichen Preis veräußert, wodurch Herr Moylan nach den Transaktionen 14.347 Aktien wirtschaftlich besitzt. Das Formular 4 wurde am 20.08.2025 eingereicht und von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moylan John Patrick

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 M 1,985 A $5.43 14,940 D
Common Stock 08/18/2025 F 593 D $5.43 14,347 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $5.43 08/18/2025 M 1,985 08/18/2025 08/18/2025 Common Stock 1,985 $5.43 3,970 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On August 18, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.21B
215.75M
0.85%
112.75%
7.94%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING